Deciphera Readies For Next Steps; Brings Third Compound Into Phase I
This article was originally published in The Pink Sheet Daily
Executive Summary
The newly relocated biotech is shifting its focus from science to business development as it moves its third compound into the clinic and begins looking for partners for its other programs.